Funding for this research was provided by:
Cell Therapy Manufacturing CRC
University President’s Postgraduate Scholarship
National Health and Medical Research Council (1102617)
Received: 10 May 2020
Revised: 15 June 2020
Accepted: 8 July 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: This research was conducted according to the University of South Australia Animal Ethics Committee following the Australian Code of Practice for the Care and the Use of Animals for Scientific Purposes (AEC: U39-18; 2 January 2019).
: Not applicable.
: The MAPC cells were provided by Athersys who hold IP protecting the use of the cells and were also a partner in the CTM CRC.